Literature DB >> 1716690

Mutational analysis of the simian immunodeficiency virus SIVmac nef gene.

D Binninger1, J Ennen, D Bonn, S G Norley, R Kurth.   

Abstract

We are using site-directed mutagenesis of single viral genes to identify and analyze the genetic determinants of human and simian immunodeficiency virus pathogenicity. In a first approach, we have constructed a series of simian immunodeficiency virus SIVmac nef mutants by partial deletion and insertions in the nef gene, as this gene is a candidate gene for the establishment and maintenance of latency. nef insertion mutants replicated faster than wild-type SIVmac, suggesting that the nef gene product acts as a negative factor for replication. Surface phenotyping revealed that cultures permanently infected with nef mutants exhibit an enhanced expression of viral proteins on the outer cell surface. We have analyzed the properties of the mutant viruses in cell culture and intend to use rapidly replicating mutants (putatively unable to undergo latency) as model vaccine viruses in the rhesus monkey.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716690      PMCID: PMC249002     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication.

Authors:  P A Luciw; C Cheng-Mayer; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

2.  A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

Authors:  J S Allan; J E Coligan; T H Lee; M F McLane; P J Kanki; J E Groopman; M Essex
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Ordered interstrand and intrastrand DNA transfer during reverse transcription.

Authors:  A T Panganiban; D Fiore
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

4.  Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma.

Authors:  H König; E Behr; J Löwer; R Kurth
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

Review 5.  AIDS: animal retrovirus models and vaccines.

Authors:  R Kurth; G Kraus; A Werner; S Hartung; P Centner; M Baier; S Norley; J Löwer
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

6.  HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product.

Authors:  B Guy; M P Kieny; Y Riviere; C Le Peuch; K Dott; M Girard; L Montagnier; J P Lecocq
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

7.  Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.

Authors:  S G Norley; G Kraus; J Ennen; J Bonilla; H König; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity.

Authors:  F Bachelerie; J Alcami; U Hazan; N Israël; B Goud; F Arenzana-Seisdedos; J L Virelizier
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses.

Authors:  H Kornfeld; N Riedel; G A Viglianti; V Hirsch; J I Mullins
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

10.  The 3'-orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukin-2 receptor and the ATP-binding site of the protein kinase family.

Authors:  K P Samuel; A Seth; A Konopka; J A Lautenberger; T S Papas
Journal:  FEBS Lett       Date:  1987-06-22       Impact factor: 4.124

View more
  10 in total

1.  Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo.

Authors:  B Beer; M Baier; J zur Megede; S Norley; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

Authors:  M Y Chowers; C A Spina; T J Kwoh; N J Fitch; D D Richman; J C Guatelli
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

3.  The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable.

Authors:  E Sinclair; P Barbosa; M B Feinberg
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef.

Authors:  O Schwartz; Y Rivière; J M Heard; O Danos
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.

Authors:  T M Niederman; J V Garcia; W R Hastings; S Luria; L Ratner
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

6.  Subcloning of HIV-2 nef genes in E. coli and immunological reactivity of expressed fusion proteins.

Authors:  R Ulrich; H Siakkou; J Mayer; N Kienzle; N Müller-Lantzsch; D H Krüger
Journal:  Virus Genes       Date:  1993-09       Impact factor: 2.332

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Interferon-gamma-activated monocytes impair infectivity of HIV particles by an oxygen metabolite-dependent reaction.

Authors:  J Ennen; R Kurth
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.

Authors:  J Ennen; H Findeklee; M T Dittmar; S Norley; M Ernst; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  The nef gene of simian immunodeficiency virus SIVmac1A11.

Authors:  R E Unger; M L Marthas; E Pratt-Lowe; P A Padrid; P A Luciw
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.